Glossary

11.5 Ethical considerations in plasma medicine research

13 min read•august 21, 2024

Plasma medicine research brings exciting possibilities, but it also raises important ethical questions. From ensuring patient safety to protecting privacy, researchers must navigate complex issues as they develop new treatments.

Ethical considerations in plasma medicine span clinical trials, device development, and emerging applications. Balancing innovation with safety, respecting cultural differences, and promoting equitable access are key challenges as the field advances.

Principles of bioethics

  • Fundamental ethical guidelines shape plasma medicine research and clinical applications
  • Ensure respect for human dignity, protection of patient rights, and promotion of overall well-being
  • Form the foundation for ethical decision-making in plasma medicine studies and treatments
Top images from around the web for Autonomy and informed consent

  • Clinical Trial Volunteer Signs Informed Consent Form | Flickr View original

    Is this image relevant?

  • Frontiers | Putting Public Health Ethics into Practice: A Systematic Framework | Public Health View original

    Is this image relevant?

  • Clinical Trial Volunteer Signs Informed Consent Form | Flickr View original

    Is this image relevant?

1 of 3

Top images from around the web for Autonomy and informed consent

  • Clinical Trial Volunteer Signs Informed Consent Form | Flickr View original

    Is this image relevant?

  • Frontiers | Putting Public Health Ethics into Practice: A Systematic Framework | Public Health View original

    Is this image relevant?

  • Clinical Trial Volunteer Signs Informed Consent Form | Flickr View original

    Is this image relevant?

1 of 3
  • Respects patients' right to make informed decisions about their medical care
  • Requires clear communication of treatment options, risks, and benefits
  • Involves obtaining voluntary agreement from patients before proceeding with plasma treatments
  • Includes the right to refuse or withdraw from treatment at any time
  • Necessitates ongoing consent as new information becomes available during research

Beneficence and non-maleficence

  • promotes actions that benefit patients and maximize positive outcomes
  • Non-maleficence requires avoiding harm or minimizing risks to patients
  • Balances potential benefits of plasma treatments against possible risks or side effects
  • Guides researchers to design studies that prioritize patient safety and well-being
  • Involves continuous monitoring and adjustment of treatments to optimize outcomes

Justice and equity

  • Ensures fair distribution of benefits and risks in plasma medicine research and applications
  • Addresses equitable access to plasma treatments across different populations
  • Considers socioeconomic factors influencing participation in clinical trials
  • Promotes diversity in research participant selection to ensure generalizability of results
  • Advocates for affordable and accessible plasma-based therapies in healthcare systems

Research ethics in plasma medicine

  • Establishes ethical standards for conducting scientific investigations in plasma medicine
  • Protects the rights, safety, and well-being of human subjects participating in studies
  • Ensures the integrity and validity of research findings to advance the field responsibly

Clinical trial design

  • Incorporates randomization and blinding techniques to minimize bias
  • Includes appropriate control groups for comparison of plasma treatments
  • Determines optimal sample sizes to achieve statistical significance
  • Establishes clear inclusion and exclusion criteria for participant selection
  • Implements rigorous data collection and analysis methods to ensure reliability
  • Considers adaptive trial designs to respond to emerging safety or efficacy data

Risk-benefit assessment

  • Evaluates potential risks of plasma treatments against expected therapeutic benefits
  • Considers both short-term and long-term effects on patient health
  • Assesses the likelihood and severity of potential adverse events
  • Compares plasma treatments to existing standard-of-care options
  • Involves multidisciplinary teams to provide comprehensive risk evaluation
  • Requires ongoing assessment throughout the research process as new data emerges

Participant selection criteria

  • Defines specific characteristics required for study inclusion
  • Considers vulnerable populations and implements additional safeguards
  • Balances scientific validity with fair representation of diverse groups
  • Addresses potential conflicts between medical need and research objectives
  • Ensures participants can safely undergo plasma treatments without undue risk
  • Implements strategies to minimize selection bias and promote generalizability

Safety considerations

  • Prioritizes patient safety throughout the development and application of plasma medicine
  • Involves continuous monitoring and evaluation of potential risks and adverse effects
  • Informs the design of safety protocols and risk mitigation strategies in clinical practice

Short-term vs long-term effects

  • Assesses immediate physiological responses to plasma treatments
  • Investigates potential delayed or cumulative effects over extended periods
  • Considers impact on cellular and molecular processes (DNA damage, oxidative stress)
  • Evaluates potential systemic effects beyond the targeted treatment area
  • Implements long-term follow-up studies to monitor for unforeseen consequences
  • Balances short-term therapeutic benefits against potential long-term risks

Potential side effects

  • Identifies common adverse reactions (skin irritation, pain, inflammation)
  • Investigates rare but serious complications (tissue damage, infection)
  • Considers potential interactions with other medical treatments or conditions
  • Assesses impact on surrounding healthy tissues during plasma application
  • Evaluates psychological effects of undergoing novel plasma treatments
  • Monitors for unexpected side effects through comprehensive reporting systems

Risk mitigation strategies

  • Implements stringent safety protocols for plasma device operation
  • Develops personalized treatment plans based on individual patient factors
  • Establishes clear guidelines for patient selection and exclusion criteria
  • Provides comprehensive training for healthcare professionals administering treatments
  • Utilizes real-time monitoring systems during plasma application
  • Implements emergency response procedures for managing adverse events

Regulatory frameworks

  • Establishes guidelines and standards for the ethical conduct of plasma medicine research
  • Ensures compliance with national and international regulations to protect patient rights
  • Provides oversight and accountability mechanisms for researchers and institutions

International guidelines

  • World Medical Association's guides ethical principles
  • International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) provides Good Clinical Practice guidelines
  • (WHO) offers ethical standards for health-related research
  • Council for International Organizations of Medical Sciences (CIOMS) provides ethical guidelines for biomedical research
  • UNESCO's Universal Declaration on Bioethics and Human Rights addresses global ethical issues
  • International Society for Plasma Medicine develops specific guidelines for the field

National regulations

  • United States Food and Drug Administration (FDA) regulates plasma devices and clinical trials
  • European Medicines Agency (EMA) oversees plasma medicine research in European Union countries
  • Japan's Pharmaceuticals and Medical Devices Agency (PMDA) provides regulatory framework
  • China's National Medical Products Administration (NMPA) governs plasma medicine research
  • Harmonization efforts aim to streamline regulatory processes across different countries
  • National ethics committees provide country-specific guidance on research conduct

Institutional review boards

  • Evaluate and approve research protocols before study initiation
  • Ensure protection of human subjects and compliance with ethical guidelines
  • Review documents for clarity and completeness
  • Monitor ongoing studies for adherence to approved protocols
  • Assess risk-benefit ratios and participant selection criteria
  • Provide guidance on ethical issues arising during research conduct
  • Ensures participants understand and voluntarily agree to plasma medicine research or treatments
  • Protects and right to make informed decisions about their healthcare
  • Involves ongoing communication and re-consent as new information becomes available
  • Explains purpose, procedures, and duration of plasma treatment or study
  • Describes potential risks, benefits, and alternatives to plasma therapy
  • Clarifies voluntary nature of participation and right to withdraw
  • Provides information on confidentiality and data protection measures
  • Includes contact information for researchers and ethics committees
  • Addresses compensation for participation and treatment of research-related injuries

Vulnerable populations

  • Implements additional safeguards for children, elderly, and mentally impaired individuals
  • Considers socioeconomic factors influencing voluntary participation
  • Addresses language barriers and cultural differences in consent process
  • Evaluates capacity to provide informed consent in cognitively impaired patients
  • Involves legal guardians or authorized representatives when necessary
  • Implements ongoing assessment of vulnerability throughout the research process
  • Develops protocols for obtaining consent in time-sensitive medical emergencies
  • Considers use of deferred consent for urgent plasma treatments
  • Implements processes for retroactive consent when immediate action is necessary
  • Involves family members or legally authorized representatives when possible
  • Balances need for timely intervention with respect for patient autonomy
  • Establishes clear criteria for waiving informed consent in life-threatening situations

Data privacy and confidentiality

  • Protects sensitive patient information collected during plasma medicine research and treatments
  • Ensures compliance with data protection regulations and ethical standards
  • Maintains trust between researchers, healthcare providers, and patients

Patient information protection

  • Implements secure data storage systems with restricted access
  • Utilizes encryption techniques for electronic health records
  • Establishes protocols for handling and transferring sensitive information
  • Trains research and medical staff on data protection policies and procedures
  • Conducts regular audits to ensure compliance with privacy regulations
  • Develops breach response plans to address potential data security incidents

Data storage and sharing

  • Utilizes secure cloud-based platforms for collaborative research projects
  • Implements data access controls based on user roles and permissions
  • Establishes data retention policies in compliance with regulatory requirements
  • Develops protocols for secure data transfer between institutions
  • Implements data backup and recovery systems to prevent loss of information
  • Considers blockchain technology for enhancing data integrity and traceability

Anonymization techniques

  • Removes personally identifiable information from research datasets
  • Utilizes pseudonymization to replace identifiers with codes
  • Implements k-anonymity to prevent re-identification of individuals
  • Considers differential privacy techniques for statistical analysis
  • Develops protocols for de-identification of medical images and scans
  • Balances data utility with privacy protection in research applications

Ethical issues in plasma device development

  • Addresses unique challenges in designing and testing novel plasma-based medical technologies
  • Balances innovation and safety considerations in device engineering
  • Considers ethical implications of commercializing plasma medicine technologies

Safety vs efficacy balance

  • Optimizes plasma parameters to maximize therapeutic effects while minimizing risks
  • Conducts extensive preclinical testing to identify potential safety concerns
  • Implements iterative design processes to refine device performance and safety features
  • Considers trade-offs between treatment efficacy and potential side effects
  • Develops personalized treatment protocols to optimize individual patient outcomes
  • Implements post-market surveillance to monitor long-term safety and efficacy

Intellectual property concerns

  • Addresses patent protection for novel plasma devices and treatment methods
  • Considers impact of intellectual property rights on accessibility of plasma treatments
  • Balances commercial interests with public health benefits
  • Develops strategies for technology transfer and licensing agreements
  • Addresses potential conflicts between academic research and industry partnerships
  • Considers open-source approaches to promote collaboration and innovation

Conflicts of interest

  • Identifies and manages financial interests of researchers and institutions
  • Implements disclosure policies for potential conflicts in publications and presentations
  • Establishes guidelines for industry sponsorship of plasma medicine research
  • Considers impact of conflicts on study design, data analysis, and result interpretation
  • Implements strategies to maintain scientific integrity and public trust
  • Develops policies for managing dual roles (researcher and clinician) in clinical trials

Cultural and religious considerations

  • Acknowledges diverse perspectives on medical treatments and research participation
  • Ensures respect for cultural and religious beliefs in plasma medicine applications
  • Promotes inclusive approaches to patient care and research participant recruitment

Diverse belief systems

  • Recognizes varying attitudes towards novel medical technologies across cultures
  • Considers religious prohibitions on certain medical interventions or treatments
  • Addresses cultural perceptions of blood and plasma in medical applications
  • Acknowledges traditional healing practices and their integration with plasma medicine
  • Respects diverse views on body modification and invasive procedures
  • Considers cultural attitudes towards participation in medical research

Cultural competence in research

  • Develops culturally sensitive recruitment strategies for clinical trials
  • Provides multilingual informed consent documents and educational materials
  • Trains research staff on cultural awareness and effective cross-cultural communication
  • Incorporates cultural factors into study design and data interpretation
  • Engages community leaders and cultural advisors in research planning
  • Considers impact of cultural beliefs on treatment adherence and follow-up

Accommodating religious practices

  • Develops protocols for scheduling treatments around religious observances (Ramadan)
  • Considers dietary restrictions in plasma-based therapies or nutritional interventions
  • Addresses concerns about gender interactions in treatment administration
  • Respects religious objections to certain medical procedures or technologies
  • Develops alternatives to blood-derived products for religious groups opposing their use
  • Considers impact of religious beliefs on end-of-life care and palliative plasma treatments

Animal research ethics

  • Establishes ethical guidelines for using animal models in plasma medicine research
  • Balances scientific necessity with animal welfare considerations
  • Promotes responsible and humane practices in preclinical studies

Alternatives to animal testing

  • Develops in vitro cell culture models for plasma treatment testing
  • Utilizes computer simulations and mathematical modeling of plasma-tissue interactions
  • Implements organ-on-a-chip technologies for studying plasma effects
  • Considers use of human tissue samples or organoids for preclinical studies
  • Explores non-invasive imaging techniques to reduce animal use
  • Implements systematic reviews to minimize redundant animal experiments

Humane treatment guidelines

  • Adheres to the 3Rs principle: Replacement, Reduction, and Refinement
  • Implements pain management protocols for animals undergoing plasma treatments
  • Establishes humane endpoints to minimize suffering in experimental procedures
  • Provides environmental enrichment for animals in long-term studies
  • Ensures proper training of personnel handling animals and administering treatments
  • Implements post-procedure monitoring and care protocols

Justification for animal use

  • Demonstrates necessity of animal models for specific plasma medicine research questions
  • Considers species-specific responses to plasma treatments in model selection
  • Balances statistical power requirements with minimizing animal numbers
  • Provides clear scientific rationale for chosen animal models and experimental designs
  • Considers ethical implications of using higher-order animals (primates)
  • Implements strategies to maximize data obtained from each animal study

Publication ethics

  • Ensures integrity and transparency in reporting plasma medicine research findings
  • Promotes responsible dissemination of scientific knowledge in the field
  • Addresses ethical challenges in the peer review and publication process

Authorship and attribution

  • Defines clear criteria for authorship based on substantial contributions
  • Addresses ghost authorship and honorary authorship issues
  • Implements transparent processes for determining author order
  • Acknowledges contributions of non-author collaborators and technical staff
  • Develops policies for handling authorship disputes in collaborative projects
  • Considers impact of authorship practices on career advancement in the field

Reporting negative results

  • Encourages publication of null or negative findings to prevent publication bias
  • Addresses challenges in publishing negative results in high-impact journals
  • Develops strategies to highlight importance of negative results in advancing knowledge
  • Considers impact of negative results on future research directions and funding
  • Implements preregistration of study protocols to ensure reporting of all outcomes
  • Addresses potential conflicts with sponsors or funders regarding negative results

Peer review integrity

  • Implements double-blind or open peer review processes to minimize bias
  • Addresses conflicts of interest in reviewer selection and management
  • Develops guidelines for ethical conduct of peer reviewers in plasma medicine
  • Implements strategies to detect and prevent peer review manipulation
  • Considers use of artificial intelligence tools to enhance peer review quality
  • Addresses challenges of finding qualified reviewers in specialized plasma medicine fields

Ethical challenges in emerging applications

  • Addresses novel ethical considerations arising from cutting-edge plasma medicine technologies
  • Anticipates potential societal impacts of advanced plasma-based treatments
  • Develops proactive approaches to address ethical concerns in rapidly evolving fields

Genetic modification concerns

  • Considers potential off-target effects of plasma on genetic material
  • Addresses ethical implications of intentional genetic modifications using plasma
  • Evaluates long-term consequences of plasma-induced epigenetic changes
  • Develops guidelines for plasma applications in gene therapy and editing
  • Considers societal implications of enhancing human genetic traits through plasma
  • Addresses concerns about germline modifications and heritable genetic changes

Nanotechnology integration

  • Evaluates safety and biocompatibility of plasma-synthesized nanoparticles
  • Addresses potential long-term accumulation of nanomaterials in the body
  • Considers ethical implications of targeted drug delivery using plasma-activated nanocarriers
  • Develops guidelines for responsible development of plasma-nanotechnology hybrid treatments
  • Addresses potential environmental impacts of nanoparticle release from plasma devices
  • Considers dual-use concerns of plasma-nanotechnology applications

Human enhancement debates

  • Addresses ethical implications of using plasma for non-medical enhancement purposes
  • Considers societal impacts of plasma treatments for cognitive or physical augmentation
  • Evaluates potential exacerbation of social inequalities through access to enhancement technologies
  • Develops guidelines for distinguishing between therapeutic and enhancement applications
  • Addresses concerns about coercion or pressure to undergo enhancement procedures
  • Considers long-term consequences of widespread human enhancement using plasma

Social and economic implications

  • Examines broader societal impacts of plasma medicine advancements
  • Addresses ethical considerations in the commercialization and distribution of plasma treatments
  • Considers economic factors influencing access to and development of plasma-based therapies

Access to plasma treatments

  • Addresses disparities in availability of plasma treatments across different regions
  • Considers impact of treatment costs on healthcare systems and individual patients
  • Develops strategies for equitable distribution of limited plasma medicine resources
  • Addresses challenges in scaling up plasma device production for widespread use
  • Considers impact of intellectual property rights on treatment accessibility
  • Develops programs to improve access in resource-limited settings

Cost-effectiveness considerations

  • Evaluates economic viability of plasma treatments compared to existing therapies
  • Considers long-term cost savings potential of plasma-based interventions
  • Develops health economic models to assess value of plasma treatments
  • Addresses challenges in reimbursement and insurance coverage for novel therapies
  • Considers impact of cost-effectiveness on treatment adoption and clinical guidelines
  • Develops strategies to reduce costs associated with plasma device manufacturing

Healthcare disparities

  • Examines potential exacerbation of existing healthcare inequalities through plasma medicine
  • Addresses disparities in research participation and representation in clinical trials
  • Considers impact of socioeconomic factors on access to advanced plasma treatments
  • Develops strategies to promote health equity in plasma medicine applications
  • Addresses challenges in implementing plasma treatments in resource-limited settings
  • Considers impact of healthcare workforce disparities on plasma treatment availability

Future ethical considerations

  • Anticipates emerging ethical challenges as plasma medicine continues to advance
  • Develops proactive approaches to address future ethical dilemmas in the field
  • Promotes ongoing dialogue and collaboration to shape ethical frameworks

Anticipating technological advances

  • Considers ethical implications of integrating artificial intelligence with plasma devices
  • Addresses potential challenges of personalized plasma medicine and precision therapies
  • Evaluates ethical concerns surrounding plasma-based organ regeneration and tissue engineering
  • Considers impact of advanced plasma diagnostics on privacy and predictive healthcare
  • Addresses potential dual-use concerns of plasma technologies in non-medical applications
  • Develops frameworks for responsible innovation in plasma medicine

Adapting ethical frameworks

  • Reevaluates existing bioethical principles in light of plasma medicine advancements
  • Develops new ethical guidelines specific to emerging plasma applications
  • Considers impact of changing societal values on plasma medicine ethics
  • Addresses challenges of applying traditional medical ethics to novel plasma therapies
  • Implements processes for regular review and update of ethical frameworks
  • Engages diverse stakeholders in shaping future ethical guidelines for plasma medicine

Global harmonization efforts

  • Promotes international collaboration to develop unified ethical standards
  • Addresses challenges of cultural and regulatory differences across countries
  • Considers impact of global health inequalities on plasma medicine development
  • Develops strategies for equitable sharing of plasma medicine knowledge and resources
  • Addresses ethical challenges in multinational clinical trials and research collaborations
  • Considers role of international organizations in promoting ethical plasma medicine practices

Key Terms to Review (18)

Access to treatment: Access to treatment refers to the ability of individuals to obtain necessary medical care and interventions in a timely and effective manner. It encompasses factors such as availability, affordability, and quality of care, all of which are crucial for ensuring that patients can receive appropriate healthcare services when needed. In the realm of plasma medicine research, access to treatment raises significant ethical questions about equity, justice, and the implications of emerging therapies for different populations.
American Medical Association: The American Medical Association (AMA) is a professional organization for physicians in the United States that aims to promote the art and science of medicine while advocating for the interests of doctors and patients. The AMA plays a crucial role in setting ethical standards for medical practice and research, ensuring that ethical considerations are prioritized in various fields, including plasma medicine.
Belmont Report: The Belmont Report is a foundational document that outlines ethical principles and guidelines for research involving human subjects. It emphasizes three core principles: respect for persons, beneficence, and justice, which are essential for protecting the rights and welfare of participants in research studies.
Beneficence: Beneficence is the ethical principle that emphasizes the moral obligation to act for the benefit of others, promoting their well-being and preventing harm. In healthcare and research contexts, it means that actions taken should contribute positively to patients or subjects involved, ensuring that their interests are prioritized and safeguarded.
Clinical trial ethics: Clinical trial ethics refers to the moral principles and guidelines that govern the conduct of research involving human participants. This encompasses the protection of participants' rights, ensuring informed consent, minimizing risks, and maximizing benefits while maintaining scientific integrity. It's essential in plasma medicine research to safeguard participants while exploring new treatments and therapies.
Conflict of Interest: A conflict of interest occurs when an individual's personal interests or loyalties could potentially compromise their professional judgment or actions. This situation can lead to biased decisions, where the individual may favor their own interests over ethical considerations, potentially undermining trust and integrity in professional fields such as plasma medicine research.
Data privacy: Data privacy refers to the protection of personal information and how it is collected, stored, and used by organizations. It involves ensuring that individuals have control over their own data and that it is handled responsibly and ethically, particularly in sensitive fields like medical research. In the context of plasma medicine research, data privacy becomes crucial due to the potential for sensitive patient information to be involved.
Declaration of Helsinki: The Declaration of Helsinki is a set of ethical principles developed by the World Medical Association to guide medical research involving human subjects. It emphasizes the importance of informed consent, the welfare of participants, and the need for research to be conducted responsibly and ethically, particularly in contexts like plasma medicine research where patient safety is paramount.
Donor compensation: Donor compensation refers to the practice of providing financial or material incentives to individuals who donate biological materials, such as blood plasma, for medical purposes. This practice raises ethical questions regarding the motivations for donation, the potential for exploitation of vulnerable populations, and the implications for the quality and safety of collected materials.
Ethical marketing: Ethical marketing refers to the practice of promoting products or services in a manner that aligns with moral values and societal norms, ensuring honesty, fairness, and respect for consumers. It emphasizes transparency, responsible messaging, and consideration of the wider impact of marketing activities on individuals and communities. In fields like plasma medicine, ethical marketing is crucial as it helps build trust and credibility in research findings and therapeutic applications.
FDA regulations: FDA regulations are rules established by the U.S. Food and Drug Administration to ensure the safety and efficacy of medical products, including drugs, devices, and biologics. These regulations provide a framework for the development, approval, and post-market surveillance of medical technologies, ensuring that they meet necessary standards before reaching patients. In the context of plasma medicine, understanding these regulations is crucial for navigating the pathways for plasma medical devices and addressing ethical considerations in research involving such technologies.
Health Disparities: Health disparities refer to the differences in health outcomes and access to healthcare that exist among different population groups, often linked to social, economic, and environmental factors. These disparities can result in poorer health outcomes for marginalized or underserved populations, emphasizing the need for equitable healthcare practices and interventions.
Informed Consent: Informed consent is the process by which a patient or participant voluntarily agrees to a medical intervention or research study, having been fully informed of its nature, benefits, risks, and alternatives. This concept is critical in ensuring that individuals understand what they are agreeing to and that their autonomy is respected, which connects to risk assessment, clinical trial design, ethical considerations, personalization of treatments, and navigating challenges in medical practice.
IRB Approval: IRB approval refers to the process by which an Institutional Review Board (IRB) reviews research proposals involving human subjects to ensure ethical standards are upheld. This process is crucial in safeguarding the rights, welfare, and privacy of participants in studies, particularly in sensitive fields like plasma medicine, where potential risks and benefits must be carefully considered.
Patient autonomy: Patient autonomy is the right of patients to make informed decisions about their own healthcare without coercion or undue influence from healthcare providers. This concept emphasizes the importance of respecting individuals' values, beliefs, and preferences when it comes to medical treatment, ensuring that patients have the power to control their own health outcomes. It is essential in maintaining ethical standards in medicine and is particularly relevant in areas like personalized treatment approaches.
Risk-benefit analysis: Risk-benefit analysis is a systematic approach to evaluating the potential risks and benefits associated with a particular action, decision, or treatment. It helps in determining whether the advantages outweigh the potential harms, guiding decisions in various fields such as healthcare and research. This concept is crucial in assessing the safety and effectiveness of innovative treatments, especially in areas like plasma medicine, where new technologies are being explored for their therapeutic potential and ethical implications.
Voluntary donation: Voluntary donation refers to the act of giving biological materials, such as plasma, willingly and without any form of coercion or financial incentive. This process is crucial in plasma medicine as it ensures that donations are made ethically and with informed consent, which is vital for both patient safety and research integrity.
World Health Organization: The World Health Organization (WHO) is a specialized agency of the United Nations responsible for coordinating global health efforts, establishing health standards, and monitoring health trends. It plays a crucial role in guiding international health policies, addressing health emergencies, and promoting research and development in various health sectors, including emerging fields like plasma medicine.
© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.
Back
Practice QuizGlossary
Practice QuizGlossary
Next guide